DowDOW
- Legal name
- Dow Inc.
- Sector
- Other
- Industry
- Plastic Materials, Synth Resins & Nonvulcan Elastomers
- Exchange
- NYSE
Stock Price $DOW
Latest filings
You are here#16 of 31 in Materials by market cap
Area = market cap · hover a tile to read it
DOW filed 7 annual reports (10-K), 24 quarterly reports (10-Q) and 94 current reports (8-K) between 2019 and 2026.
- 8-K · Mar 13, 2019
- 8-K · Mar 18, 2019
- 8-K · Apr 1, 2019
- 8-K · Apr 2, 2019
- 8-K · May 2, 2019
- 10-Q · May 3, 2019
- 8-K · May 20, 2019
- 8-K · May 20, 2019
- 8-K · Jun 3, 2019
- 8-K · Jun 13, 2019
- 10-Q · Jul 25, 2019
- 8-K · Jul 25, 2019
- 8-K · Jul 25, 2019
- 8-K · Aug 5, 2019
- 8-K · Aug 16, 2019
- 8-K · Sep 23, 2019
- 8-K · Oct 11, 2019
- 8-K · Oct 24, 2019
- 10-Q · Oct 25, 2019
- 8-K · Jan 29, 2020
- 10-K · Feb 7, 2020
- 8-K · Feb 18, 2020
- 8-K · Feb 25, 2020
- 8-K · Apr 13, 2020
- 8-K · Apr 30, 2020
- 10-Q · May 1, 2020
- 8-K · Jul 23, 2020
- 10-Q · Jul 24, 2020
- 8-K · Aug 13, 2020
- 8-K · Aug 17, 2020
- 8-K · Aug 20, 2020
- 8-K · Aug 26, 2020
- 8-K · Sep 15, 2020
- 8-K · Sep 30, 2020
- 8-K · Oct 22, 2020
- 10-Q · Oct 23, 2020
- 8-K · Jan 28, 2021
- 10-K · Feb 5, 2021
- 8-K · Feb 11, 2021
- 8-K · Mar 4, 2021
- 8-K · Mar 25, 2021
- 8-K · Apr 16, 2021
- 8-K · Apr 22, 2021
- 10-Q · Apr 23, 2021
- 8-K · Apr 23, 2021
- 8-K · Jul 22, 2021
- 10-Q · Jul 23, 2021
- 8-K · Aug 16, 2021
- 8-K · Oct 6, 2021
- 8-K · Oct 21, 2021
- 10-Q · Oct 22, 2021
- 8-K · Jan 27, 2022
- 8-K · Feb 3, 2022
- 10-K · Feb 4, 2022
- 8-K · Feb 10, 2022
- 8-K · Apr 18, 2022
- 8-K · Apr 21, 2022
- 10-Q · Apr 22, 2022
- 8-K · Jul 21, 2022
- 10-Q · Jul 22, 2022
- 8-K · Oct 20, 2022
- 10-Q · Oct 21, 2022
- 8-K · Oct 26, 2022
- 8-K · Jan 26, 2023
- 8-K/A · Jan 26, 2023
- 8-K · Jan 26, 2023
- 8-K · Jan 31, 2023
- 10-K · Feb 1, 2023
- 8-K · Apr 18, 2023
- 8-K · Apr 25, 2023
- 10-Q · Apr 26, 2023
- 8-K · Jul 25, 2023
- 10-Q · Jul 26, 2023
- 8-K · Oct 24, 2023
- 10-Q · Oct 25, 2023
- 8-K · Oct 25, 2023
- 8-K · Dec 18, 2023
- 8-K · Jan 25, 2024
- 8-K · Jan 30, 2024
- 10-K · Jan 31, 2024
- 8-K · Feb 9, 2024
- 8-K · Feb 20, 2024
- 8-K · Apr 15, 2024
- 8-K · Apr 25, 2024
- 10-Q · Apr 26, 2024
- 8-K · May 16, 2024
- 8-K · Jul 25, 2024
- 10-Q · Jul 26, 2024
- 8-K · Sep 12, 2024
- 8-K · Oct 24, 2024
- 10-Q · Oct 25, 2024
- 8-K · Dec 3, 2024
- 8-K · Dec 9, 2024
- 8-K · Jan 30, 2025
- 8-K · Jan 30, 2025
- 8-K · Feb 3, 2025
- 10-K · Feb 4, 2025
- 8-K · Feb 25, 2025
- 8-K · Mar 11, 2025
- 8-K · Apr 15, 2025
- 8-K · Apr 24, 2025
- 10-Q · Apr 25, 2025
- 8-K · May 1, 2025
- 8-K · Jun 11, 2025
- 8-K · Jul 7, 2025
- 8-K · Jul 24, 2025
- 10-Q · Jul 25, 2025
- 8-K · Sep 2, 2025
- 8-K · Sep 8, 2025
- 8-K · Oct 23, 2025
- 10-Q · Oct 24, 2025
- 8-K · Jan 5, 2026
- 8-K · Jan 29, 2026
- 8-K · Jan 29, 2026
- 8-K · Feb 2, 2026
- 10-K · Feb 3, 2026
- 8-K · Apr 14, 2026
- 8-K · Apr 23, 2026
- 10-Q · Apr 24, 2026
- 8-K/A · Jul 6, 2026
- 8-K · Jul 10, 2026
- 8-K · Jul 23, 2026
- 10-Q · Jul 24, 2026
- 8-K · Oct 22, 2026
- 10-Q · Oct 23, 2026
01—Key figures
Revenue Trend
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025
- $39.97B
Latest bar from 10-KFY2025Click a bar to open its SEC filingTap a bar to open its SEC filing
View full history →All DOW Financial Metrics57 metrics
Income Statement14
Balance Sheet26
- Cash & ST Investments
- Total Assets
- Current Assets
- Cash
- Short-Term Investments
- Receivables
- Inventory
- Prepaid & Other
- PP&E
- Goodwill
- Intangibles
- Other Non-current
- Total Liabilities
- Current Liabilities
- Accrued Liabilities
- Short-Term Debt
- Deferred Revenue
- Long-Term Debt
- Other Non-current Liab.
- Equity
- Retained Earnings
- Accumulated OCI
- APIC
- Treasury Stock
- NCI
- Total L&E
Cash Flow12
02—Overview
Dow Financial Overview 2021–2025
Updated Nov 3, 2026Dow Inc. suffered a devastating collapse in profitability, shifting from a $1.12 billiona net income in FY2024 to a staggering $2.62 billion net loss in FY2025. This massive deficit forces a harsh reality on investors: the chemical giant is aggressively shrinking its operational footprint and cutting shareholder returns to survive persistent global overcapacity.
The top-line erosion was systematic, as revenue plummeted from $55 billionb in FY2021 to just $40 billion in FY2025. To stem the bleeding, management launched a radical cost-cutting campaign. The company slashed its quarterly dividend by 50% to $0.35 per share in Q3 2025 and initiated restructuring programs that will eliminate approximately 4,500 roles. These aggressive plant shutdowns and asset write-downs generated massive impairment charges. The market heavily discounted this deterioration, leaving the stock at a closing price of $23.38 at the end of FY2025.
However, early indicators suggest the restructuring is taking hold. By Q2 2026, the company posted a 20% year-over-year surge in net sales to $12.1 billionc, largely fueled by a 30% jump in local prices for its Packaging & Specialty Plastics segment. This top-line recovery returned the company to profitability with a $721 million net income, signaling that management's structural overhaul is beginning to restore basic earnings power.
Recent Developments (Q2 and Q3 2026)
Momentum held into Q3 2026, but it is slowing. Net sales rose 13% to $11.3 billiond, down from the 20% pace in Q2 2026. Local prices rose 14% while volume fell 1%, so growth is price-driven. Operating EBIT reached $887 million versus $180 million in Q3 2025, though it fell from $1.66 billion in Q2 2026. Net income was $458 million, down from $721 million in Q2 2026. Free cash flow was $1.1 billion for the quarter. Karen Carter became CEO in July, with base pay rising to $1.5 million. Management expects over $1.3 billion of in-year self-help benefits.
Bull case: price gains, cost savings, and $2.446 billione of nine-month free cash flow are lifting earnings. Bear case: volume is falling, and the stock closed at $32.61 as of October 22, 2026, with trailing annual EPS of -$3.70, so a P/E is not meaningful and the price rests on recovery continuing.
What to watch: whether volume turns positive as price gains fade; progress on Transform to Outperform savings
03—Filings
Recent SEC Filings
- 8-KDow 8-K Report, Financial Results (Oct 22, 2026)Dow Inc. reported strong third-quarter 2026 results, with net sales increasing by 13% year-over-year to $11.3 billion, driven by broad-based price increases across all operating segments. Local prices rose 14%, particularly in Packaging & Specialty Plastics, due to higher polyethylene prices. While overall volume saw a slight 1% decrease, this was largely attributed to impacts from the Middle East conflict in the Asia Pacific region, with other regions showing volume growth. The company demonstrated significant operational improvement, with Operating EBIT soaring to $887 million, a substantial increase from the prior year, fueled by higher pricing and successful self-help initiatives that effectively offset rising raw material and logistics costs. Financially, Dow generated $1.8 billion in cash from operating activities, a considerable year-over-year improvement, and achieved $1.1 billion in free cash flow. The company also returned $253 million to shareholders through dividends. Management highlighted the ongoing success of its "Transform to Outperform" strategy and cost reduction programs, which are on track to deliver significant EBITDA uplift, underscoring a focus on enhanced competitiveness and long-term shareholder value creation. Despite external challenges like geopolitical conflicts, Dow's disciplined execution and strategic initiatives are driving improved profitability and cash generation.
- 8-KDow 8-K Report, Financial Results (Jul 23, 2026)Dow Inc. reported second-quarter 2026 results on July 23, 2026, with net sales of $12.1 billion, up 20% year-over-year, driven almost entirely by price (local price up 20%, led by higher polyethylene prices in all regions) rather than volume, which fell 1%. GAAP net income was $802 million (GAAP EPS $0.99) versus a net loss of $801 million a year earlier, and Operating EBIT rose to $1.65 billion from a loss of $21 million. Management credits higher prices and the Transform to Outperform self-help program for the improvement. Operating EPS of $1.44 excludes $0.45 per share of significant items, mainly $605 million pretax of Transform to Outperform costs, partly offset by a $150 million income tax benefit tied to a NOVA Chemicals payment. Cash flow was solid: operating cash flow from continuing operations was $1.3 billion and free cash flow was $692 million, though working capital absorbed cash as receivables and inventories grew with revenue. Dividends of $253 million were paid in the quarter. Total debt is roughly $17.9 billion, and cash was $4.0 billion at June 30, 2026. Management said it expects roughly $200 million of additional Transform to Outperform benefits in 2026, bringing total in-year self-help benefits above $1.3 billion, and that the impact of these efforts should ramp further through the rest of 2026 and into 2027. For investors, the key questions are how durable the price-driven margin expansion is, whether volumes recover (Middle East conflict and planned maintenance weighed on results), and whether the restructuring costs and Sadara-related charges taper as guided. The filing itself is a furnished Item 2.02 notice attaching the earnings press release; it does not include new guidance beyond the qualitative outlook in the release.
- 8-KDow 8-K Report, Corporate Update (Jul 10, 2026)Dow Inc. has filed a Current Report on Form 8-K on July 10, 2026, primarily to announce the registration of 5,410,000 shares of its common stock. These shares are being registered under the Company's existing Form S-3 registration statement. The purpose of this registration is to cover shares that may be issued upon the exercise, settlement, or vesting of certain awards granted under the Dow Inc. 2019 Stock Incentive Plan, specifically for awards not eligible for registration on a Form S-8. This filing is a procedural step to ensure these shares can be legally issued to employees or other award recipients.
- 8-KDow 8-K/A Report, Executive Changes (Jul 6, 2026)Dow Inc. (DOW) has filed an amendment to its prior 8-K filing to disclose updated material changes to Karen S. Carter's compensation in her new role as Chief Executive Officer, effective July 1, 2026. The Board of Directors approved significant adjustments to her base salary, annual cash incentive target, and long-term incentive compensation. These changes reflect the increased responsibilities associated with the CEO position and align with the company's executive compensation structure. Investors should note the substantial increase in Ms. Carter's total compensation package, particularly in her long-term incentive awards and target annual cash incentive. The company has also detailed the proration of her 2026 annual cash incentive based on her Chief Operating Officer and CEO roles. A one-time long-term incentive award has been granted, structured with performance-based units, stock options, and restricted stock units, designed to incentivize long-term value creation and retention.
- 8-KDow 8-K Report, Financial Results (Apr 23, 2026)Dow Inc. reported first quarter 2026 results on April 23, 2026, with net sales of $9.8 billion, down 6% year-over-year, driven by a 7% decline in local prices and a 2% volume decline. The headline GAAP net loss was $445 million (GAAP loss per share of $0.74), compared with a loss of $290 million a year earlier. Operating EBIT fell to $154 million from $230 million, and operating EPS was a loss of $0.14 versus earnings of $0.02 in the prior-year quarter. Management attributed the weakness mainly to lower prices, partly offset by cost reduction benefits, and said margins began to inflect positively in March as Middle East conflict-related supply constraints spread. The GAAP results were heavily affected by significant items totaling $0.60 per share, most notably a $292 million pretax Sadara guarantee liability adjustment (which Dow said pushed its equity loss recognition to suspended status once carrying values reached total existing obligations) and a $150 million income tax charge tied to the NOVA Chemicals litigation receipt. Cash flow improved sharply: operating cash flow from continuing operations was $1.1 billion, up $1.0 billion, largely from the NOVA payment and working capital gains, producing free cash flow of $621 million versus negative $581 million a year earlier. Dow paid $252 million in dividends during the quarter. For investors, the key tension is between a weak underlying earnings base and early signs of a pricing recovery. Management pointed to announced price increases across all businesses and regions and a 'Transform to Outperform' program as drivers of future growth and margins, but the filing gives no quantified guidance, and the Sadara exposure and litigation-related cash inflows make reported figures less representative of recurring performance.
04—See also
Related Companies
Annual revenue over each company’s last eight fiscal years, each strip on its own scale from zero.